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Amphibians have been widely used to investigate the synthesis of biologically active
steroids in the brain and the regulation of neurosteroid production by neurotransmitters
and neuropeptides. The aim of the present review is to summarize the current knowl-
edge regarding the neuroanatomical distribution and biochemical activity of steroidogenic
enzymes in the brain of anurans and urodeles. The data accumulated over the past two
decades demonstrate that discrete populations of neurons and/or glial cells in the frog
and newt brains express the major steroidogenic enzymes and are able to synthesize de
novo a number of neurosteroids from cholesterol/pregnenolone. Since neurosteroidogen-
esis has been conserved during evolution from amphibians to mammals, it appears that
neurosteroids must play important physiological functions in the central nervous system
of vertebrates.
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INTRODUCTION
Steroid hormones play a crucial role in the development, growth,
and differentiation of the central nervous system (CNS; McEwen,
1992; Compagnone and Mellon, 2000; Sakamoto et al., 2001;
Karishma and Herbert, 2002; Wang et al., 2005; Lazaridis et al.,
2011). Because of their lipophilic nature, circulating steroids
can readily cross the blood–brain barrier, and it has long been
assumed that the adrenal gland, gonads, and placenta were the
sole sources of steroid hormones acting on the brain. However,
in the early 1980s, Baulieu, Robel, and co-workers made a series
of seminal observations which revealed that this view was not
correct. They initially found that the concentrations of several
steroids,including pregnenolone (Δ5P),dehydroepiandrosterone
(DHEA), and their sulfate esters, were much higher in the cen-
tral and peripheral nervous systems than in the plasma (Cor-
péchot et al., 1981, 1983). They then reported that the level
of certain brain steroids remained elevated after adrenalectomy
and castration, and that ACTH treatment, although increasing
plasma Δ5P level, did not affect Δ5P concentration in brain
tissue (Corpéchot et al., 1981, 1983; Robel and Baulieu, 1985;
Cheney et al., 1995). These observations led them to hypothesize
that the brain had the capability of synthesizing de novo biolog-
ically active steroids. In support of this hypothesis, the presence
of steroidogenic enzymes has now been visualized by immuno-
histochemistry and in situ hybridization, either in neurons or
in glial cells, in the brain of various representative vertebrate
species, and the occurrence of the corresponding enzymatic
activities has been ascertained through biochemical approaches
(Mensah-Nyagan et al., 1999; Tsutsui et al., 1999; Compagnone
and Mellon, 2000; Mellon and Vaudry, 2001; Do Rego et al.,
2009).
Concurrently, it has been shown that brain-born steroids
(now called neurosteroids) exert pleiotropic activities in the CNS.
Neurosteroids act either via conventional nuclear receptors or
via allosteric modulation of membrane receptors, e.g., GABAA,
glycine,NMDA,kainate,AMPA,sigma,nicotinic,muscarinic,and
serotonergicreceptors(Majewska,1992;BelelliandLambert,2005;
Belelli et al.,2006; Herd et al.,2007).
The amphibian brain is a very convenient model to study neu-
rosteroidogenesis.Firstly,mostenzymesofthesteroidogenicpath-
waysareexpressedintheCNSofamphibians.Secondly,theactivity
of the steroidogenic enzymes in the brain of amphibians is very
high,thusmakingitpossibletoinvestigatetheeffectsof inhibitory
factorsregulatingneurosteroidogenesis.Thirdly,becauseof itsrel-
atively small size, the brain of amphibians is particularly suitable
for studying the neuroanatomical distribution of neurosteroid-
producing cells. The present report summarizes the current
knowledge concerning the occurrence, distribution, and biolog-
ical activity of steroidogenic enzymes in the brain of amphibians.
A companion paper describes the neuronal mechanisms involved
intheregulationof neurosteroidogenesisinamphibians(DoRego
et al., submitted).
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TRANSLOCATOR PROTEIN
Translocator protein (TSPO) is an 18-kDa protein that is part
of the peripheral benzodiazepine receptor complex (Papadopou-
los et al., 2006). TSPO, which is primarily located on the outer
mitochondrialmembrane,bindswithhighafﬁnitycholesteroland
enhances its translocation to the inner mitochondrial membrane
(Papadopoulos et al.,1997;Rupprecht et al.,2009). In the brain of
the European green frog Rana esculenta,the distribution of TSPO
has been determined by immunohistochemistry using polyclonal
antibodiesagainstasyntheticfragmentofthehumanprotein(Oke
et al., 1992). TSPO-immunoreactive cells are located in several
nuclei of the telencephalon and diencephalon including the ante-
riorcommissure,thelateralandmedialpallium,thelateralseptum,
the medial amygdala, the anterior preoptic area, the dorsal hypo-
thalamic nucleus, the posterior tuberculum, the suprachiasmatic
nucleus,and the ventral habenular nucleus (Do Rego et al.,1998).
Interestingly, in several of these nuclei, TSPO is co-localized with
the steroidogenic enzyme 3β-hydroxysteroid dehydrogenase (3β-
HSD) supporting the involvement of TSPO in the biosynthesis of
neurosteroids in the frog brain (Do Rego et al.,1998).
STEROID ACUTE REGULATORY PROTEIN
Steroid acute regulatory protein (StAR) is a 30-kDa protein that
plays a major role in the transfer of cholesterol from the outer to
theinnermembraneofmitochondria(Stocco,2001).StARmRNA
is actively expressed in the brain of mammals including human
(Furukawa et al., 1998; Inoue et al., 2002). In the human frontal
cortex, immunohistochemical studies have shown that StAR and
cytochrome P450 side-chain cleavage (P450scc) co-exist in a dis-
crete population of neurons. The expression of the StAR gene has
alsobeenevidencedinthebrainof birds(Londonetal.,2006)and
ﬁsh (Nunez et al., 2005; Lyssimachou and Arukwe, 2007; Arukwe,
2008; Kusakabe et al., 2009). However, up to now, the occurrence
of StAR has not yet been investigated in the frog brain (Do Rego
et al.,2009).
CYTOCHROME P450 SIDE-CHAIN CLEAVAGE
Cytochrome P450scc (CYP11A1), a member of the cytochrome
P450 superfamily of enzymes, is located on the inner mitochon-
drial membrane (Farkash et al., 1986). P450scc is a rate-limiting
and hormonally regulated enzyme that catalyzes the conversion
of cholesterol into Δ5P, the universal precursor of all steroid hor-
mones(Guoetal.,2007;LavoieandKing,2009;Figure1).P450scc
wastheﬁrststeroidogenicenzymewhosepresencewasdetectedin
theCNS(LeGoascogneetal.,1987).Sincethen,theoccurrenceof
P450scc has been reported in the brain of rodents (Compagnone
et al., 1995a; Ukena et al., 1998; Kimoto et al., 2001) and pri-
mates (Le Goascogne et al., 1989)a sw e l la si nb i r d s( Tsutsui
and Yamazaki, 1995; Usui et al., 1995; Lea et al., 2001; London
et al., 2006). In amphibians, the localization of P450scc has been
described in both anurans and urodeles. In the clawed toad Xeno-
pus laevis and the frog Rana nigromaculata,P450scc is particularly
FIGURE 1 | Biochemical pathways for the synthesis of neurosteroids.The
color code is the same as that used in Figures 2–6. Abbreviations for steroids:
B, corticosterone; C, cholesterol; CS, cholesterol sulfate; Δ
4,
androstenedione; Δ
5P , pregnenolone; Δ
5PS, pregnenolone sulfate; DHEA,
dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulfate; DHDOC,
dihydrodeoxycorticosterone; DHP , dihydroprogesterone; DHT,
dihydrotestosterone; E1, estrone; E2, estradiol; P , progesterone;T,
testosterone;THDOC, tetrahydrodeoxycorticosterone;THP ,
tetrahydroprogesterone; 3α-diol, androstanediol; 7α-OH-Δ
5P,
7α-hydroxypregnenolone; 7α-OH-DHEA, 7α-hydroxydehydroepiandrosterone;
11-DOC, 11-deoxycorticosterone; 17OH-Δ
5P , 17-hydroxypregnenolone; 17OH-P ,
17-hydroxyprogesterone. Abbreviations for enzymes: AKR1C,
3α-hydroxysteroid dehydrogenase; CYP7A1, oxysterol 7α-hydroxylase
(cytochrome P4507α); CYP11A1, cytochrome P450 side-chain cleavage;
CYP11B1, 11β-hydroxylase (cytochrome P450C11); CYP17A1, cytochrome
P450 17α-hydroxylase/C17 , 20-lyase; CYP19A1, cytochrome P450 aromatase;
CYP21, 21-hydroxylase (P450C21); HSD3B,3 β-hydroxysteroid
dehydrogenase/Δ
5-Δ
4 isomerase; HSD17B,1 7 β-hydroxysteroid
dehydrogenase; SRD5A,5 α-reductase; STS, sulfatase; SULT2, hydroxysteroid
sulfotransferase.
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abundantintheventralhypothalamicnucleusandthemedialpal-
lium(Takaseetal.,1999).P450scc-immunoreactivityisalsopresent
in the anterior preoptic area, the dorsal and lateral pallium, the
dorsal striatum, the ventral part of the magnocellular preoptic
nucleus, the optic tectum, the pretectal gray, Purkinje cells in the
cerebellum, and lamina six (Takase et al., 1999). In R. esculenta,
P450scc-immunoreactivity is found in both neurons and glial cells
(unpublished observations). The fact that the concentrations of
Δ5P in the brain of X. laevis (Takase et al., 1999), R. esculenta
(Mensah-Nyagan et al., 1994), and the red-bellied newt Cynops
pyrrhogaster (Inai et al., 2003) are higher than in the plasma and
eventhegonadssuggeststhattheP450scc-immunoreactiveprotein
detected in the brain of these amphibian species actually corre-
sponds to a biologically active form of the enzyme. In support
of this hypothesis, a recent study has shown the conversion of
cholesterol into Δ5P in the newt brain (Takase et al.,2011).
3β-HYDROXYSTEROID DEHYDROGENASE
3β-Hydroxysteroid dehydrogenase/Δ4-Δ5 isomerase (3β-HSD;
HSD3B) is a membrane bound enzyme that catalyzes the conver-
sion of Δ5-3β-hydroxysteroids into Δ4-3-ketosteroids (Figure1).
This enzyme is thus essential for the biosynthesis of all classes
of steroid hormones including progesterone (P), glucocorticoids,
mineralocorticoids, androgens, and estrogens (Payne and Hales,
2004;Simardetal.,2005).Theexistenceof 3β-HSDmRNAand/or
protein has been documented in the brain of mammals (Dupont
etal.,1994;Guennounetal.,1995;SanneandKrueger,1995;Ukena
etal.,1999a)andbirds(Ukenaetal.,1999b,2001).Inamphibians,
the neuroanatomical distribution of 3β-HSD immunoreactivity
has been described in the CNS of R. esculenta (Mensah-Nyagan
et al., 1994) and C. pyrrhogaster (Inai et al., 2003). In adult frog,
3β-HSD-containing neurons are exclusively located in the dien-
cephalon, namely in the anterior preoptic area and the dorsal
and ventral hypothalamic nuclei (Figure 2). These neurons send
projections in the telencephalon, notably in the nucleus accum-
bens, and in various nuclei of the diencephalon (Mensah-Nyagan
et al., 1994). During early development (stages IV–XII), intense
3β-HSD immunoreactivity is found in the dorsal part of the
anterior olfactory nucleus (Bruzzone et al., 2010). The concen-
tration of P in the frog hypothalamus is about 200-fold higher
than in the plasma (Mensah-Nyagan et al., 1994). Likewise, in
the brain of the toad X. laevis and the newt C. pyrrhogaster,P
levels are higher than in the plasma and gonads (Takase et al.,
1999; Inai et al., 2003) suggesting that brain P does not originate
fromsteroidogenicglands.Consistentwiththisnotion,incubation
of frog hypothalamic explants or newt brain homogenates with
tritiated pregnenolone ([3H]Δ5P) yields to the formation of vari-
ous newly synthesized steroids including [3H]P (Mensah-Nyagan
et al., 1994; Inai et al., 2003). Taken together, these observations
indicate that 3β-HSD immunoreactivity detected in the brain of
amphibians is biologically active.
CYTOCHROME P4507α
Cytochrome P4507α (P4507α; CYP7A1) is a microsomal enzyme
with broad substrate speciﬁcity for sterol metabolites (Gilardi
et al., 2007; Norlin and Wikvall, 2007; Figure 1). One of the
FIGURE2|S c hematic parasagittal section depicting the distribution of
3β-hydroxysteroid dehydrogenase (3β-HSD)-immunoreactive cell
bodies (stars) and ﬁbers (dots) in the central nervous system of Rana
esculenta (Mensah-Nyagan et al., 1994).The anatomical structures are
designated according to the nomenclature of Northcutt and Kicliter (1980)
and Neary and Northcutt (1983). C, cerebellum; CP , corpus geniculatum
thalamicum; Hyp, hypothalamus; NPv, nucleus of the periventricular organ;
OB, olfactory bulb; OC, optic chiasma; OT, optic tectum; Pal, pallium; Poa,
anterior preoptic area; Pdis, pars distalis; PI, pars intermedia; PN, pars
nervosa; Rh, rhombencephalon; Sep, septum;Teg, tegmental nuclei;TP ,
posterior tuberculum.
isoforms of P4507α, CYP7B, is expressed in the brain of mam-
mals (Stapleton et al., 1995) and birds (Tsutsui et al., 2008).
The ﬁrst evidence for the presence of P4507α in the brain of
amphibians was provided by Matsunaga et al. (2004) who showed
that the brain of the newt C. pyrrhogaster actively converts
[3H]Δ5P into tritiated 7α-hydroxypregnenolone ([3H]7α-OH-
Δ5P). Subsequently, CYP7B was cloned from the newt brain
conﬁrming the occurrence of P4507α in the CNS of amphibians
(Haraguchi et al., 2010). Newt CYP7B-transfected COS-7 cells
can catalyze the conversion of [3H]Δ5P into [3H]7α-OH-Δ5P,
and the enzymatic activity is blocked by the cytochrome P450
inhibitor ketoconazole (Haraguchi et al.,2010). In the newt brain,
CYP7B-immunoreactive cells are primarily located in the ante-
rior preoptic area, the magnocellular preoptic nucleus, and the
tegmental area. Immunoreactive cells are also found in the lateral
anddorsalpallium,thesuprachiasmaticnucleus,theventralhypo-
thalamic nucleus, and the tectum mesencephali (Haraguchi et al.,
2010).Recentstudieshaveshownthatthesynthesisof7α-OH-Δ5P
in the newt brain undergoes marked diurnal and seasonal varia-
tions in parallel with changes in locomotor activity (Matsunaga
et al., 2004; Tsutsui et al., 2008, 2010a,b; Haraguchi et al., 2009;
Koyama et al., 2009). The observation that 7α-OH-Δ5P biosyn-
thesis in the newt brain is stimulated by melatonin (Tsutsui et al.,
2010a) and prolactin (Haraguchi et al., 2010) strongly suggests
that these two factors are responsible, respectively, for the diurnal
andseasonalvariationsin7α-OH-Δ5Pformation.Thefunctional
signiﬁcance of 7α-OH-Δ5P in the control of locomotor activity is
discussed in a companion paper (Haraguchi et al.,2011).
CYTOCHROME P450 17α-HYDROXYLASE/C17,20-LYASE
The microsomal enzyme cytochrome P450 17α-hydroxylase/C17,
20-lyase (P450C17; CYP17A1) possesses 17α-hydroxylase activity
and can thus convert Δ5P into 17-hydroxypregnenolone (17OH-
Δ5P) and P into 17-hydroxyprogesterone (17OH-P; Figure 1).
P450C17 also possesses 17,20-lyase activity and can thus con-
vert 17OH-Δ5P into DHEA and 17OH-P into androstenedione
(Δ4; Miller, 2008; Figure 1). The search for the existence of
P450C17 in the brain of mammals has led to controversial results
www.frontiersin.org November 2011 | Volume 2 | Article 79 | 3Vaudry et al. Neurosteroid biosynthesis in amphibians
(Le Goascogne et al., 1991; Mellon and Deschepper, 1993; Com-
pagnone et al., 1995b; Yamada et al., 1997; Hojo et al., 2004).
In contrast, the occurrence of P450C17 has been unequivocally
demonstrated in the CNS of birds (Matsunaga et al., 2001) and
amphibians (Do Rego et al., 2007). In R. esculenta, P450C17
immunoreactivity is essentially located in neurons, notably in
the diencephalon, but a few P450C17-positive glial cells are also
observed in the mesencephalon (Do Rego et al., 2007). Thus, a
denseaccumulationofP450C17-immunoreactiveneuronsisfound
in the anterior preoptic area, the ventral hypothalamic nuclei, the
magnocellular nuclei, the posterior tuberculum, the habenular
nuclei, and the nucleus of the periventricular organ. P450C17-
positive neurons are also present in the olfactory bulb, the lateral
amygdala and the medial pallium (Do Rego et al.,2007;Figure3).
Frog hypothalamic explants are capable of converting [3H]Δ5P
into C2117-hydroxysteroids and C19 ketosteroids such as 17OH-
Δ5P,17OH-P,DHEA,andΔ4 (DoRegoetal.,2007)indicatingthat
CYP17 expressed in the brain of amphibians actually possesses
17α-hydroxylase and C17–20-lyase activities.
5α-REDUCTASE
3-Oxo-5α-steroid 4-dehydrogenase, more commonly termed 5α-
reductase (5α-R; SRD5A), is a microsomal enzyme that catalyzes
the conversion of P to dihydroprogesterone (DHP) and the con-
version of testosterone (T) to dihydrotestosterone (DHT; Russell
and Wilson, 1994; Figure 1). In the brain, 5α-R is involved in
thebiosyntheticpathwayof 3α,5α-tetrahydroprogesterone(THP)
also called allopregnanolone, a potent allosteric modulator of the
GABAA receptor. 5α-R is also responsible for the formation of
the potent androgen DHT. The occurrence of 5α-reductase in
the brain of mammals, including humans, has long been docu-
mented (Saitoh et al., 1982; Pelletier et al., 1994; Melcangi et al.,
1998; Torres and Ortega, 2003). In amphibians, the ontogeny
of 5α-reductase has been recently investigated in the brain of
R. esculenta (Bruzzone et al., 2010). In the diencephalon, 5α-
R-immunoreactive cell bodies are mainly found in the vascular
plexuses,theepiphysis,theventralpartoftheinfundibularnucleus
and the preoptic nucleus. In the mesencephalon, positive cells are
located in the anterodorsal and anteroventral nuclei, the interpe-
duncularnucleus,theposterocentralandposterolateralnuclei,the
torus semicircularis, and the central gray layer of the tectum. In
themetencephalon,transientexpressionof5α-Roccursinthecor-
puscerebelliatstageX–XIIwhenhindlimbsarelengthening.Inthe
rhombencephalon,5α-R-containingcellsarepresentinthemedial
FIGURE3|S c hematic parasagittal section depicting the distribution of
cytochrome P450C17 (P450C17)-immunoreactive cell bodies (stars) and
ﬁbers (dots) in the central nervous system of Rana esculenta (Do Rego
et al., 2007). For other designations, see Figure 2.
longitudinalfascicleandthesuperﬁciallayer(Bruzzoneetal.,2010;
Figure 4). Interestingly, in the tadpole brain, 5α-R immunoreac-
tivity is found in both bipolar neurons and in glial cells (Vallarino
et al., 2005). Incubation of tadpole brain explants with [3H]Δ5P
leads to the formation of several metabolites including P,17OH-P,
Δ4, and 5α-DHT (Bruzzone et al., 2010) indicating that biologi-
cally active 3β-HSD, P450C17, and 5α-R are already present in the
CNS of amphibians during development.
3α-HYDROXYSTEROID DEHYDROGENASE
3α-Hydroxysteroid oxidoreductase, also called 3α-hydroxysteroid
dehydrogenase (3α-HSD; AKR1C) is a microsomal enzyme that
catalyzes in a reversible manner the conversion of 5α-DHP and
5α-DHT into THP (allopregnanolone) and 3α-androstanediol,
respectively (Figure 1). 3α-HSD is also involved in the
reversible conversion of dihydrodeoxycorticosterone (DHDOC)
into tetrahydrodeoxycorticosterone (THDOC; Penning et al.,
2000; Figure 1). A single form of 3α-HSD exists in rodents
(Pawlowski et al., 1991) while four isoforms have been character-
izedinhumans(Khannaetal.,1995).Thedistributionof 3α-HSD
mRNA and protein has been described in the brain of human
(Grifﬁn and Mellon,1999; Steckelbroeck et al., 2001) and rodents
(Khanna et al., 1995; Agís-Balboa et al., 2006), but has not yet
been reported in amphibians. Using an antibody against human
3α-HSD, we have recently observed the existence of 3α-HSD-
immunoreactiveneuronsinthebrainof R.esculenta.Positivecells
arefoundintheolfactorybulb,theanteriorcommissure,theante-
rior preoptic area,the magnocellular preoptic nucleus,the ventral
hypothalamic nucleus, the posterior thalamic nucleus, and the
posterior tuberculum (unpublished observations). We have also
seen that frog hypothalamic explants can synthesize THP from
[3H]Δ5P (unpublished observations), indicating that a bioactive
form of 3α-HSD is actually present in the brain of amphibians.
17β-HYDROXYSTEROID DEHYDROGENASE
17β-Hydroxysteroid dehydrogenase (17β-HSD; HSD17B)i sa
bifunctional enzyme that catalyzes the interconversion of 17-
ketosteroids and 17β-hydroxysteroids (Payne and Hales, 2004).
17β-HSDthusplaysapivotalroleinthebiosynthesisandinactiva-
tion of sex steroid hormones (Figure 1). Twelve isoforms of 17β-
HSD exhibiting different substrate speciﬁcity, tissue expression,
andsubcellularlocalizationhavebeencharacterizedinvertebrates
(Luu-The,2001;Luu-Theetal.,2006).Theoccurrenceof17β-HSD
FIGURE4|S c hematic parasagittal section depicting the distribution of
5α-reductase (5α-R)-immunoreactive cell bodies (stars) and ﬁbers
(dots) in the developing central nervous system of Rana esculenta at
developmental stage XIX–XXV (Bruzzone et al., 2010). For other
designations, see Figure 2.
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has been demonstrated in the brain of mammals (Pelletier et al.,
1995;Hojoetal.,2004)andbirds(Nomuraetal.,1998;Matsunaga
et al., 2002). In amphibians, immunohistochemical localization
of 17β-HSD has been determined in the CNS of the frog Rana
ridibunda using polyclonal antibodies against type I human pla-
cental 17β-HSD (Dupont et al., 1991). In this species, 17β-HSD
immunoreactivity is found in a discrete population of glial cells.
Positivegliocytesarelocatedinthetelencephalon,i.e.,theperiven-
tricular zone of the medial pallium, and in the rostral region of
the diencephalon (Mensah-Nyagan et al., 1996a,b; Figure 5). The
presenceof substantialamountsof Tinthebrainof bothmaleand
female frogs has been shown by gas chromatography–mass spec-
trometry and by HPLC analysis combined with radioimmunoas-
say(Mensah-Nyaganetal.,1996a,b).Inmalefrogs,castrationdoes
notaffecttheconcentrationofTand5α-DHTinthetelencephalon
andhypothalamus(Mensah-Nyaganetal.,1996b).Finally,invitro
studies have demonstrated that frog telencephalon explants can
convert [3H]Δ5P into [3H]T and [3H]5α-DHT (Mensah-Nyagan
et al., 1996a,b). Altogether, these data provide strong evidence for
the existence of a bioactive form of 17β-HSD in the forebrain of
amphibians and for the biosynthesis of sex steroids from Δ5Pb y
glial cells of the telencephalon and diencephalon.
CYTOCHROME P450 AROMATASE
Cytochrome P450 aromatase (P450arom; CYP19AI) is a micro-
somal enzyme that catalyzes the transformation of androgens
into estrogens (Simpson et al., 2002; Figure 1). It has long been
established that aromatization of androgens is required for their
regulatory effects in the CNS (MacLusky and Naftolin, 1981).
Thus,P450aromplaysacrucialroleinthesexualdifferentiationof
the brain and in the regulation of reproductive functions (Garcia-
Segura,2008). The distribution of P450arom has been extensively
investigated in the brain of mammals (Roselli et al., 1985; Balt-
hazart et al., 1991; Abdelgadir et al., 1997) and birds (Balthazart
et al., 1990; Evrard et al., 2004). The occurrence and localiza-
tion of P450arom has also been described in the brain of teleost
ﬁsh (Callard et al., 1978; Gelinas and Callard, 1997; Goto-Kazeto
et al., 2004; Diotel et al., 2010). In amphibians, the presence of
P450arom has been reported in the brain of Necturus maculosus
(Callard et al.,1978) and R. esculenta (Guerriero et al.,2000). The
expression of P450arom mRNA in the brain of Pleurodeles waltl
(Kuntz et al., 2004) and X. laevis (Urbatzka et al., 2007) has been
investigated during development. In both species, the P450arom
FIGURE5|S c hematic parasagittal section depicting the distribution of
17β-hydroxysteroid dehydrogenase (17β-HSD)-immunoreactive cell
bodies (stars) and ﬁbers (dots) in the central nervous system of Rana
esculenta (Mensah-Nyagan et al., 1996a,b). For other designations, see
Figure 2.
gene is expressed from early developmental stages to metamor-
phosis without noticeable differences between males and females.
However, the precise neuroanatomical distribution of P450arom
mRNA or protein has not yet been determined in any amphib-
ian species. Incubation of frog hypothalamic homogenates with
[3H]DHEA induces the formation of estrone sulfate (Beaujean
et al., 1999). Similarly, incubation of frog hypothalamic explants
with [3H]Δ5P yields to the biosynthesis of estradiol (Mensah-
Nyaganetal.,1996a,b).Takentogether,theseobservationsindicate
that, in amphibians as in other vertebrate groups, an active form
of aromatase is present in the brain.
HYDROXYSTEROID SULFOTRANSFERASE
Hydroxysteroidsulfotransferase(HST;SULT2)designatesafamily
of cytosolic enzymes that transfer the sulfonate moiety from 3-
phosphoadenosine 5-phosphosulfate (PAPS) on the 3-hydroxyl
or the 21-hydroxyl group of steroid substrates (Strott, 2002;
Figure1). The observation that 3-hydroxysteroid sulfonates,such
as pregnenolone sulfate (Δ5PS) and dehydroepiandrosterone sul-
fate (DHEAS), act as allosteric modulators of various receptors
forneurotransmitters,notablyGABAA receptors(Majewska,1992;
Le Foll et al., 1997) indicates that HST plays a critical role in
the bioactivation of certain neurosteroids. Remarkably, while in
mammals, immunohistochemical studies failed to detect HST in
the brain (Sharp et al., 1993), in amphibians, the occurrence of
HSTimmunoreactivityhasbeenthoroughlyinvestigatedinR.ridi-
bunda (Beaujean et al.,1999). Using an antiserum against rat liver
HST,twopopulationsof HST-immunoreactiveneuronshavebeen
visualizedinthedorsalpartof themagnocellularpreopticnucleus
andtheanteriorpreopticarea(Figure6).Theseneuronssendpro-
jectionsinvariousregionsofthetelencephalon,diencephalon,and
mesencephalon, notably in the medial amygdala, medial pallium,
medial septum,nucleus accumbens,nucleus of the diagonal band
of Broca, anterior thalamic nucleus, posterior thalamic nucleus,
anterior preoptic area,basal optic nucleus,and nucleus reticularis
isthmi (Beaujean et al., 1999). Incubation of frog telencephalon
or hypothalamus homogenates with [3H]Δ5Po r[ 3H]DHEA as
steroid precursors and [35S]PAPS as a sulfate donor yields the
formation of several 3H, 35S-labeled steroids including Δ5PS,
DHEAS, and testostosterone sulfate (TS; Beaujean et al., 1999).
De novo synthesis of 3-hydroxysteroid sulfate is blocked by the
sulfotransferase inhibitor 2,4-dichloro-6-nitrophenol (Beaujean
et al.,1999). These data demonstrate that the brain of amphibians
FIGURE6|S c hematic parasagittal section depicting the distribution of
hydroxysteroid sulfotransferase (HST)-immunoreactive cell bodies
(stars) and ﬁbers (dots) in the central nervous system of Rana
esculenta (Beaujean et al., 1999). For other designations, see Figure 2.
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expresses HST and has the ability to synthesize the highly potent
neurosteroids Δ5PS and DHEAS.
CONCLUDING REMARKS
Amphibians have been widely used as animal models to investi-
gate neurosteroid biosynthesis in the brain. The neuroanatomical
distribution of most key steroidogenic enzymes has now been
determined in the brain of anurans and/or urodeles. For some
of these enzymes, e.g., 3β-HSD and HST, the immunohistochem-
ical localization in the CNS has been ﬁrst reported in amphibians.
Biochemical studies have demonstrated that these enzymes are
able to convert radiolabeled steroid precursors such as [3H]Δ5P
or [3H]DHEA into biologically active steroids. The occurrence
of high concentrations of steroids in brain tissue conﬁrms that
amphibians have the ability to synthesize neurosteroids which
are, at least in part, produced independently of steroidogenic
glands. The fact that amphibians and mammals, which diverged
approximately 350 million years ago, have in common the ability
to synthesize de novo biologically active steroids in their brain
supports the view that neurosteroids are playing vital functions
throughout the animal kingdom.
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